SC 13D/A | 2023-03-10 | Sumitomo Chemical Co., Ltd. | Myovant Sciences Ltd. | 45,798,176 | 100.0% | EDGAR |
SC 13D/A | 2023-03-06 | Sumitomo Chemical Co., Ltd. | Myovant Sciences Ltd. | 50,041,181 | 51.5% | EDGAR |
SC 13G | 2023-02-17 | Alpine Global Management, LLC | Myovant Sciences Ltd. | 6,425,084 | 6.6% | EDGAR |
SC 13G/A | 2023-02-14 | BB BIOTECH AG | Myovant Sciences Ltd. | 5,872,639 | 6.0% | EDGAR |
SC 13G/A | 2023-02-09 | JANUS HENDERSON GROUP PLC | Myovant Sciences Ltd. | 1,177,158 | 1.2% | EDGAR |
SC 13G | 2023-02-09 | FIL Ltd | Myovant Sciences Ltd. | 8,624,543 | 8.9% | EDGAR |
SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | Myovant Sciences Ltd. | 7,333 | 0.0% | EDGAR |
SC 13D/A | 2022-10-24 | Sumitomo Chemical Co., Ltd. | Myovant Sciences Ltd. | 50,041,181 | 51.7% | EDGAR |
SC 13D/A | 2022-10-03 | Sumitomo Chemical Co., Ltd. | Myovant Sciences Ltd. | 50,041,181 | 52.2% | EDGAR |
SC 13G/A | 2022-02-11 | BB BIOTECH AG | Myovant Sciences Ltd. | 6,122,039 | 6.6% | EDGAR |
SC 13G/A | 2022-02-10 | JANUS HENDERSON GROUP PLC | Myovant Sciences Ltd. | 5,527,464 | 5.9% | EDGAR |
SC 13G | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | Myovant Sciences Ltd. | 6,063,802 | 6.5% | EDGAR |
SC 13D/A | 2021-10-27 | Sumitomo Chemical Co., Ltd. | Myovant Sciences Ltd. | 50,041,181 | 54.4% | EDGAR |
SC 13D/A | 2021-09-17 | Sumitomo Chemical Co., Ltd. | Myovant Sciences Ltd. | 49,678,522 | 54.0% | EDGAR |
SC 13D/A | 2021-05-17 | Sumitomo Chemical Co., Ltd. | Myovant Sciences Ltd. | 48,641,181 | 53.2% | EDGAR |
SC 13G/A | 2021-02-12 | BB BIOTECH AG | Myovant Sciences Ltd. | 4,757,039 | 5.3% | EDGAR |
SC 13G/A | 2021-02-11 | JANUS HENDERSON GROUP PLC | Myovant Sciences Ltd. | 5,098,315 | 5.6% | EDGAR |
SC 13D/A | 2020-05-15 | Sumitomo Chemical Co., Ltd. | Myovant Sciences Ltd. | 48,468,472 | 54.0% | EDGAR |
SC 13D/A | 2020-04-16 | Sumitomo Chemical Co., Ltd. | Myovant Sciences Ltd. | 47,488,604 | 52.9% | EDGAR |
SC 13D/A | 2020-03-26 | Sumitomo Chemical Co., Ltd. | Myovant Sciences Ltd. | 46,508,604 | 51.8% | EDGAR |